M. A. Le Bot

Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes

M. A. Le Bot, Jean M. Bégué, Dominique Kernaleguen et al. · Biochemical Pharmacology · 1988 · 71 citations

Pharmacy, Biochemistry, Pharmacology +13

Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans*

Laurent Becquemont, Isabelle Ragueneau, M. A. Le Bot et al. · Clinical Pharmacology & Therapeutics · 1997 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Toxic Effects of Tacrine on Primary Hepatocytes and Liver Epithelial Cells in Culture

Dominique Lagadic‐Gossmann, Maryvonne Rissel, M. A. Le Bot et al. · Cell Biology and Toxicology · 1998 · 50 citations

Pharmacy, Pharmacology, Toxicology +16

Use of heterologously expressed human cytochrome P4501A2 to predict tacrine-fluvoxamine drug interaction in man

Laurent Becquemont, M. A. Le Bot, Christian Richeb et al. · Pharmacogenetics · 1998 · 34 citations

Medicine, Pharmacokinetics, Pharmacology +17

A cellular model for drug interactions on hematopoiesis: The use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis

Marie Chantal Léglise, P Darodes de Tailly, J. L. Vignot et al. · Cell Biology and Toxicology · 1996 · 18 citations

Medicine, Hematology, Pharmacology +14